Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Syngene's G:BOXChemi Used in Microbial Research at Wageningen UR

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
To contribute to understanding how bacterial immune systems function.

Syngene has announced that one of its G:BOXChemi imaging systems is being used at the Wageningen UR (University & Research centre) to visualize and analyze bacterial proteins as part of a research programme to understand the molecular mechanisms behind bacterial immune systems.

Scientists in the Laboratory of Microbiology at Wageningen UR are using a G:BOXChemi system to accurately image both chemiluminescent and fluorescently labelled Western blots of multi-functional protein complexes belonging to the CRISPR/Cas proteins.

These proteins degrade foreign DNA, thus protecting bacteria from infection and by studying them, the scientists hope to unravel how bacterial immune systems function.

Determining pathways of bacterial immunity could lead to a number of applications, such as being able to immunize industrially important bacteria used in food production and large-scale fermentations against phage infection.

Raymond Staals, a Researcher at Wageningen UR said: “We undertake RNAi studies and then assess protein expression on Western blots. However, performing chemi blots in our facility used to be such a hassle as we’d have to develop X-ray films and then take photos. We decided it needed to be simpler so tried using a laser-based scanner but this was limited to chemi blots and it was complicated to work with as we weren’t given any instruction on how to use it.”

Staals continued: “We want to work with fluorescent and chemi Westerns and need a system which can analyze a whole range of different dye types. We looked at two CCD-based imagers and decided on the G:BOXChemi because the system is very user-friendly as the GeneSys software guides you through everything. We currently use the G:BOXChemi regularly to image agarose and acrylamide DNA or RNA gels and sometimes to image plate-assays of bacteria expressing fluorescent luciferase. The system is very popular as many other researchers and students come to use the G:BOXChemi to image DNA gels now instead of using our old gel doc as the quality of the images is so much better.”

Laura Sullivan, Syngene’s Divisional Manager concluded: “We are pleased to discover the Laboratory of Microbiology at Wageningen UR has chosen Syngene’s system to be part of their specialist microbial genetics programme. Their work demonstrates that a G:BOX Chemi multi-functional image analyzer is ideally suited for use by students and experienced scientists alike and is versatile enough to be used with confidence to produce great results regardless of the blot or gel type used.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!